NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

T3 Defense Share Price Continues to Decline

Overview

On March 20, T3 Defense's share price hit new lows, plummeting 10.4% to $0.95 apiece. This significant decline brings the month-to-date drop to 59%. The company, formerly Nukkleus Inc., has experienced a substantial decline in its share price over the past year, plummeting 95% from $16 to the current price.

Recent Developments

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

In recent months, T3 Defense has witnessed increased demand for integrated air and missile defence and counter-UAS capabilities amid the ongoing Iran conflict and broader geopolitical developments. The company has reaffirmed its commitment to supporting national security requirements while prioritizing the safety of its employees, customers, and suppliers in affected regions.

Company Profile

T3 Defense is a federated holding company focused on acquiring and operating mission-critical defence businesses embedded in long-cycle national security programmes. The company targets defence businesses operating at constrained, qualification-driven, or execution-critical points across the industrial base, where strategic value exists and where qualification, capacity, and execution are decisive.

Key Statistics

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

  • Current share price: $0.95
  • Month-to-date drop: 59%
  • Past year decline: 95%
  • Record high (December 2024): $65.65
  • Record low (March 2024): $0.95

Investor Takeaway

Investors should be cautious of T3 Defense stock due to its significant decline and potential for further selling pressure.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.